Comparison of non-vitamin K antagonist oral anticoagulants and well-controlled warfarin in octogenarians with non-valvular atrial fibrillation: Real-world data from a single tertiary center

被引:0
作者
Akgun, Arzu Neslihan [1 ]
Karacaglar, Emir [1 ]
Bal, Ugur Abbas [1 ]
Ozin, Mehmet Bulent [1 ]
机构
[1] Baskent Univ, Fac Med, Dept Cardiol, Ankara, Turkey
关键词
atrial fibrillation; embolism; octogenarian; anticoagulants; stroke; STROKE PREVENTION; ELDERLY-PATIENTS; RISK-FACTOR; RIVAROXABAN; PREVALENCE; MANAGEMENT;
D O I
10.5152/AnatolJCardiol.2021.25058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, and its prevalence increases with age. Nevertheless, data about the use of oral anticoagulants (OACs) among patients with >= 80 years remains limited. This study aimed to evaluate the efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in octogenarians with non-valvular AF (NVAF). Methods: Medical records of 387 patients who were >= 80 years and diagnosed with NVAF in our hospital between January 2017 and December 2019 were evaluated retrospectively. Patients with NVAF were divided into 2 groups (NOACs and warfarin), and the incidence of stroke/systemic embolism and major bleeding were analyzed. Results: A total of 322 patients were included in the study. The median follow-up duration was 10.9 months for the NOACs group and 12.1 months for the warfarin group. The primary efficacy outcome was stroke/systemic embolism, and the primary safety outcome was major bleeding. A total of 220 patients were taking NOACs, and the most preferred NOACs were apixaban (53.6%), rivaroxaban (29.5%), dabigatran (13.2%), and edoxaban (3.6%) in this order. During a mean follow-up of 302.7 patient-years, the incidence of stroke or systemic embolic events was slightly higher among patients with warfarin but the difference was not statistically significant (p=0.862). The incidence rates of major bleeding events were similar between the treatment groups (p=0.824). Conclusion: Our study revealed that the safety and efficacy outcomes are similar between the 2 treatment groups in octogenarians with NVAF.
引用
收藏
页码:462 / 467
页数:6
相关论文
共 21 条
  • [1] ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)
    Basaran, Ozcan
    Beton, Osman
    Dogan, Volkan
    Tekinalp, Mehmet
    Aykan, Ahmet Cagri
    Kalaycioglu, Ezgi
    Bolat, Ismail
    Tasar, Onur
    Safak, Ozgen
    Kalcik, Macit
    Yaman, Mehmet
    Altun, Ibrahim
    Soylu, Mustafa Ozcan
    Kirma, Cevat
    Biteker, Murat
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (10) : 734 - 741
  • [2] Belmonte M, 2019, E J CARDIOLOGY PRACT, V17, P6
  • [3] Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation An Observational Cohort Study
    Bonde, Anders Nissen
    Lip, Gregory Y. H.
    Kamper, Anne-Lise
    Fosbol, Emil L.
    Staerk, Laila
    Carlson, Nicholas
    Torp-Pedersen, Christian
    Gislason, Gunnar
    Olesen, Jonas Bjerring
    [J]. STROKE, 2016, 47 (11) : 2707 - 2713
  • [4] Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
    Chao, Tze-Fan
    Liu, Chia-Jen
    Lin, Yenn-Jiang
    Chang, Shih-Lin
    Lo, Li-Wei
    Hu, Yu-Feng
    Tuan, Ta-Chuan
    Liao, Jo-Nan
    Chung, Fa-Po
    Chen, Tzeng-Ji
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    [J]. CIRCULATION, 2018, 138 (01) : 37 - 47
  • [5] Epidemiology of atrial fibrillation in Turkey: preliminary results of the multicenter AFTER* study
    Ertas, Faruk
    Kaya, Hasan
    Kaya, Zekeriya
    Bulur, Serkan
    Kose, Nuri
    Gul, Mehmet
    Eren, Nihan Kahya
    Cagliyan, Caglar Emre
    Koroglu, Bayram
    Vatan, Bulent
    Acar, Goksel
    Yuksel, Murat
    Bilik, Mehmet Zihni
    Gedik, Selcuk
    Simsek, Ziya
    Akil, Mehmet Ata
    Yilmaz, Rustem
    Oylumlu, Mustafa
    Aribas, Alpay
    Yildiz, Abdulkadir
    Aydin, Mesut
    Yeter, Ekrem
    Kanadasi, Mehmet
    Ergene, Oktay
    Ozhan, Hakan
    Ulgen, Mehmet Siddik
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 (02): : 99 - 104
  • [6] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Phillips, KA
    Chang, YC
    Henault, LE
    Selby, JV
    Singer, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18): : 2370 - 2375
  • [7] Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Wojdyla, Daniel M.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Patel, Manesh R.
    Breithardt, Guenter
    Singer, Daniel E.
    Becker, Richard C.
    Hacke, Werner
    Paolini, John F.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Califf, Robert M.
    Fox, Keith A. A.
    [J]. CIRCULATION, 2014, 130 (02) : 138 - U45
  • [8] Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iwamoto, Kazuya
    Tajiri, Masahiro
    [J]. CIRCULATION JOURNAL, 2012, 76 (09) : 2104 - 2111
  • [9] 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
    January, Craig T.
    Wann, L. Samuel
    Alpert, Joseph S.
    Calkins, Hugh
    Cigarroa, Joaquin E.
    Cleveland, Joseph C., Jr.
    Conti, Jamie B.
    Ellinor, Patrick T.
    Ezekowitz, Michael D.
    Field, Michael E.
    Murray, Katherine T.
    Sacco, Ralph L.
    Stevenson, William G.
    Tchou, Patrick J.
    Tracy, Cynthia M.
    Yancy, Clyde W.
    [J]. CIRCULATION, 2014, 130 (23) : 2071 - 2104
  • [10] Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates
    Kannel, WB
    Wolf, PA
    Benjamin, EJ
    Levy, D
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8A) : 2N - 8N